These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 38628650)

  • 1. Different therapeutic approaches in melasma: advances and limitations.
    Ghasemiyeh P; Fazlinejad R; Kiafar MR; Rasekh S; Mokhtarzadegan M; Mohammadi-Samani S
    Front Pharmacol; 2024; 15():1337282. PubMed ID: 38628650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders.
    Verma P; Yadav KS
    Expert Opin Drug Deliv; 2023 Jun; 20(6):773-783. PubMed ID: 37086183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New oral and topical approaches for the treatment of melasma.
    Grimes PE; Ijaz S; Nashawati R; Kwak D
    Int J Womens Dermatol; 2019 Feb; 5(1):30-36. PubMed ID: 30809577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural options for management of melasma, a review.
    Nomakhosi M; Heidi A
    J Cosmet Laser Ther; 2018; 20(7-8):470-481. PubMed ID: 29461133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.
    Cohen PR
    Med Hypotheses; 2017 Apr; 101():1-5. PubMed ID: 28351480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Insights in Melasma and Hyperpigmentation Management.
    Huerth KA; Hassan S; Callender VD
    J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Treatments for Melasma and Post-inflammatory Hyperpigmentation.
    Sadick N; Pannu S; Abidi Z; Arruda S
    J Drugs Dermatol; 2023 Nov; 22(11):1118-1123. PubMed ID: 37943277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials.
    Pennitz A; Kinberger M; Avila Valle G; Passeron T; Nast A; Werner RN
    Br J Dermatol; 2022 Sep; 187(3):309-317. PubMed ID: 35290681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid in melasma: A focused review on drug administration routes.
    Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melasma in Latin America: options for therapy and treatment algorithm.
    Cestari T; Arellano I; Hexsel D; Ortonne JP;
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Melasma Treatments.
    Jo JY; Chae SJ; Ryu HJ
    Ann Dermatol; 2024 Jun; 36(3):125-134. PubMed ID: 38816973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment.
    Hatem S; Elkheshen SA; Kamel AO; Nasr M; Moftah NH; Ragai MH; Elezaby RS; El Hoffy NM
    Drug Deliv; 2022 Dec; 29(1):1212-1231. PubMed ID: 35403519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedling with cutaneous delivery of topical agents for the treatment of melasma: A systematic review.
    Brasil Dos Santos J; Nagem Lopes LP; de Lima GG; Teixeira da Silva R; da Silva E Souza Lorca B; Miranda Pinheiro G; Faria de Freitas ZM
    J Cosmet Dermatol; 2022 Nov; 21(11):5680-5695. PubMed ID: 35933690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of melasma: a review of less commonly used antioxidants.
    Babbush KM; Babbush RA; Khachemoune A
    Int J Dermatol; 2021 Feb; 60(2):166-173. PubMed ID: 32815582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of topical formulations for melasma.
    de Freitas ACP; Rigon RB; Bagatin E; Leonardi GR
    Int J Dermatol; 2023 Feb; 62(2):260-268. PubMed ID: 36083295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Melasma: Laser and Other Therapies-Review Study.
    Jiryis B; Toledano O; Avitan-Hersh E; Khamaysi Z
    J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for melasma.
    Rajaratnam R; Halpern J; Salim A; Emmett C
    Cochrane Database Syst Rev; 2010 Jul; (7):CD003583. PubMed ID: 20614435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The formulation and efficacy of topical
    Javedan K; Hydarpur F; Mohammadi Pour P; Najafi F; Mirzaeei S; Rahimi R; Gravandi MM; Farzaei MH
    J Complement Integr Med; 2022 Sep; 19(3):743-751. PubMed ID: 33964194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of laser-related therapy for melasma: A systematic review and network meta-analysis.
    Ma W; Gao Q; Liu J; Zhong X; Xu T; Wu Q; Cheng Z; Luo N; Hao P
    J Cosmet Dermatol; 2023 Nov; 22(11):2910-2924. PubMed ID: 37737021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.